NCT01881347View on ClinicalTrials.gov

Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

March 1, 2015

Study Completion Date

July 31, 2016

Conditions
Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Resveratrol

Resveratrol 100 mg daily for 2 weeks followed by resveratrol 300 mg daily for 2 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo 100 mg daily for 2 weeks followed by placebo 300 mg daily for 2 weeks.

Trial Locations (1)

02118

Boston University Medical Center, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Boston University

OTHER

NCT01881347 - Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter